Australia – China Science and Innovation Forum fosters collaboration and commercialisation

By Christine Filippis / June 28, 2023
The 2023 Australia-China Science and Innovation Forum focused on leading-edge Australian and Chinese biomedical research collaborations and commercialisation. The forum...
Read More

Cell Therapy Potency Assay Summit reveals exclusive insights on regulatory interactions and potency assay development

By Christine Filippis / June 16, 2023
Cartherics’ Acting Chief Scientific Officer, Dr Walid Azar recently attended the 2nd Cell Therapy Potency Assay Summit in Boston. The...
Read More

Global IP takes centre stage at the 21st Advanced Summit on Life Sciences Patents

By Christine Filippis / May 30, 2023
Cartherics’ Director of IP & Licensing, Telma Mantas recently attended the ACI’s 21st Advanced Summit on Life Sciences Patents in...
Read More

Cartherics to present at the 2023 BIO International Convention

By Christine Filippis / May 24, 2023
Melbourne, Australia, 24 May 2023 – Cartherics Pty Ltd, a biotechnology company developing immune cell therapies for the treatment of...
Read More

Cartherics congratulates Rasa Islam on PhD success

By Christine Filippis / May 16, 2023
Cartherics is delighted to announce that Rasa Islam has successfully completed her PhD candidature. Rasa’s research thesis, titled, Re-engineering the...
Read More

Cartherics to present at the CIMT Annual Meeting in Germany

By Christine Filippis / May 2, 2023
Cartherics is pleased to announce that PhD Candidate, Van To, will be presenting at the Association for Cancer Immunotherapy’s 20th...
Read More

Cartherics grants Shunxi Licence for CAR-T Cell Therapy for Ovarian Cancer in Greater China

By Christine Filippis / April 28, 2023
Melbourne, Australia, 28 April 2023 –  Cartherics Pty Ltd ("Cartherics"), a biotechnology company developing immune cell therapies for the treatment...
Read More

Cartherics’ offsite provides the opportunity to connect, engage and grow

By Christine Filippis / April 14, 2023
Cartherics recently held a company offsite at the RACV Healesville Country Club and Resort. Nestled in the beautiful Yarra Valley...
Read More

Cartherics proudly supports the White Shirt Campaign

By Christine Filippis / April 11, 2023
Cartherics is hosting a White Shirt Day lunch on 8th May to help raise funds and awareness for ovarian cancer....
Read More

Cartherics to present at ThymOz 2023

By Christine Filippis / March 22, 2023
Cartherics will be presenting at the ThymOZ 2023 International Conference on T Cells to be held from 22 -26 March...
Read More

Cartherics to present at prestigious oncology conference in France

By Christine Filippis / March 3, 2023
Cartherics is pleased to announce that Dr Vera Evtimov, Project Manager and Principal Scientist, will be presenting her work in...
Read More

Cartherics to present at Australia Biologics 2023

By Christine Filippis / February 28, 2023
Cartherics is pleased to announce that Dr Madeline Cao, Research Fellow, will be presenting at Australia Biologics 2023 at Crown...
Read More

Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Ovarian Cancer

By Christine Filippis / February 27, 2023
Melbourne, Victoria, Australia 27 February 2023 Peter MacCallum Cancer Centre (“Peter Mac”) and Cartherics Pty Ltd (“Cartherics”) announced today they...
Read More

Cartherics is ‘Turning Teal’ this February in support of ovarian cancer

By Christine Filippis / February 22, 2023
Cartherics is delighted to be hosting a Teal Tea this February to raise awareness and funds for people affected by...
Read More

Cartherics celebrates PhD student’s success

By Christine Filippis / February 6, 2023
Cartherics is delighted to announce that Saleh Almasabi has successfully completed his PhD Candidature. Saleh’s research thesis, ‘The role of...
Read More